09/28/2004
Federal Register Notice: FDA is making available a draft document entitled Guidance for Industry and FDA Staff: Application User F...09/28/2004
Federal Register Notice: FDA has determined that the regulatory review period for Novartis Corp.’s Reyataz (atazanavir sulfa...09/28/2004
Federal Register Notice: FDA’s collection of information entitled “Health and Diet Survey — 2004 Supplement̶...09/28/2004
Federal Register Notice: FDA has determined that the regulatory review period for Amgen’s Kineret (anakinra) is 4,101 days f...09/28/2004
Federal Register Notice: FDA has determined that the regulatory review period for Visudyne (verteporfin) is 3,194 days for extendi...09/28/2004
Federal Register Notice: FDA is announcing the availability of a cumulative list of exceptions and alternative procedures to requi...09/28/2004
Federal Register Notice: FDA will hold a public meeting 11/18: “Second Annual Stakeholder Meeting on the Implementation of t...09/24/2004
Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a Merial Ltd. supplemental new ani...